A federal judge has dismissed the second amended complaint filed by a nationwide class that had claimed it suffered economic damages from the recall of medicine, including Tylenol, manufactured in a now-closed Fort Washington, Pa., plant operated by a subsidiary of Johnson & Johnson.

None of the 24 named plaintiffs alleged facts sufficient to support standing, U.S. District Judge Mary A. McLaughlin of the Eastern District of Pennsylvania ruled.